ConductScience.org, home
MDA-MB-231
API referenceFor AI assistants

Cell line · CVCL_0062

Papers845

3 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.

1 to 20 of 845

Download this page as JSON
PaperJournalYearHow we knowRetractedSource
Comprehensive characterization of the cellular and molecular consequences of LCN2 loss in MDA-MB-231 triple-negative breast cancer cellsFront Cell Dev Biol2026Its Methods give the RRID and name the linePubMed
PubMed 43004984Yale J Biol Med2026Its Methods give the RRID and name the linePubMed
Genetically engineered RNA inducers of proximity for protein regulation.Nat Commun2026Its Methods give the RRID and name the linePubMed
Overcoming platinum resistance by the disulfiram metabolite CuET in novel preclinical models of human carcinomas.Mol Oncol2026Its Methods give the RRID and name the linePubMed
A Novel Bioengineering Approach to Breast Cancer Invasion In Vitro Through Enhancing the Value of Existing Breast Cancer Epithelial Lineages.Cells2026Its Methods give the RRID and name the linePubMed
Potent Antineoplastic Activity against Breast Cancer in Vitro and in Vivo of a Chloro-Substituted Polyaromatic Platinum(II) Complex and Its Platinum(IV) Prodrug.ACS Omega2026Its Methods give the RRID and name the linePubMed
Mitochondrial transfer between breast cancer cells promotes ROS-dependent proliferation.bioRxiv2026Its Methods give the RRID and name the linePubMed
Integrative Assessment of Teucrium Extracts: Phytochemical Profile, Nutritional-Mineral Composition, Biological Activities, and Toxicological Assessment In Vitro and In Vivo.Chem Biodivers2026Its Methods give the RRID and name the linePubMed
VCP-Regulated LMF2 Stabilizes the Cholesterol Biosynthesis Enzyme HMGCS1 to Drive Cancer Progression and Confer Capecitabine Resistance in Triple-Negative Breast Cancer.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
IL-1β/IL-6 inflammatory crosstalk drives DNA methylation and histone remodeling associated with cytokine induced senescence in luminal breast cancer.Inflamm Res2026Its Methods give the RRID and name the linePubMed
ZBTB1 Regulates Glycolysis and Chemotherapy Resistance Through Interacting with c-Myc in Triple Negative Breast Cancer.Cancers (Basel)2026Its Methods give the RRID and name the linePubMed
Isolated Cembranoid Diterpenes From Sarcophyton tenuispiculatum and Semi‑Synthetic Derivatives with Pro‑Apoptotic Activity in Breast Cancer Cells.Chem Biodivers2026Its Methods give the RRID and name the linePubMed
Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy.Mol Oncol2026Its Methods give the RRID and name the linePubMed
Mechanical fingerprints in breast cancer research: A multimodal experimental approach.Bioeng Transl Med2026Its Methods give the RRID and name the linePubMed
Actinomycin Analogs From Streptomyces polyantibioticus S4D258: Structural Elucidation and Antiproliferative Activity Against Triple-Negative Breast Cancer.Chem Biodivers2026Its Methods give the RRID and name the linePubMed
Immunomagnetic-MXene Bifunctional Probes for Ultrasensitive and Specific Terahertz Metasensing of Tumor-Derived Exosomes.Adv Sci (Weinh)2026Its Methods give the RRID and name the linePubMed
Exosomes from Cancer-associated Fibroblasts Orchestrate Lung Metastasis of Breast Cancer via LncRNA LMAEP.J Cancer2026Its Methods give the RRID and name the linePubMed
Antitumor-Relevant Evaluation of Liquid and Microencapsulated Lepidium meyenii and Bactris gasipaes Extracts Reveals Species- and Formulation-Dependent Activity.Molecules2026Its Methods give the RRID and name the linePubMed
Neutrophil extracellular traps induce chemoresistance in human breast cancer cells through the PI3K/AKT/NF-κB pathway.Front Immunol2026Its Methods give the RRID and name the linePubMed
Pogostemon Cablin Aqueous Extract (PCAE) Induces Mitotic Delay by Downregulating CDC2/Cyclin B1 in TNBC Cells (MDA-MB-231).Biochem Res Int2026Its Methods give the RRID and name the linePubMed

cell-lines-2026-11-14-0.1.0

Next page

Sources 4

  • CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
  • PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
  • NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
  • PubMedNLM's terms
Each source's terms
  • CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
  • PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
  • NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
  • PubMedNLM's terms

Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/cell-lines/v1/CVCL_0062/papers

API referenceFor AI assistants